
Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours
Keywords: سرطانهای سر و گردن; Ridaforolimus; mTOR inhibitor; MK-0752; Notch inhibitor; Head and neck cancer; Phase I;